Page 433 - IJB-10-4
P. 433

International Journal of Bioprinting                               Pregabalin impact on 3D neuronal models




               midbrain dopaminergic neurons.  Front Pharmacol.   68.  Aruga J. The role of Zic genes in neural development. Mol
               2022;13:923113.                                    Cell Neurosci. 2004;26(2):205-221.
               doi: 10.3389/fphar.2022.923113                     doi: 10.1016/j.mcn.2004.01.004
            57.  Saino‐Saito S, Berlin R, Baker H. Dlx‐1 and Dlx‐2 expression   69.  Inoue T, Ota M, Ogawa M, Mikoshiba K, Aruga J.
               in the adult mouse brain: relationship to dopaminergic   Zic1 and Zic3 regulate medial forebrain development
               phenotypic regulation. J Comp Neurol. 2003;461(1):18-30.  through  expansion of  neuronal  progenitors.  J Neurosci.
               doi: 10.1002/cne.10611                             2007;27(20):5461-5473.
            58.  Cecchi C. Emx2: a gene responsible for cortical development,      doi: 10.1523/JNEUROSCI.4046-06.2007
               regionalization and area specification.  Gene. 2002;   70.  Butt SJ, Sousa VH, Fuccillo MV, et al. The requirement of
               291(1-2):1-9.                                      Nkx2-1 in the temporal specification of cortical interneuron
               doi: 10.1016/s0378-1119(02)00623-6                 subtypes. Neuron. 2008;59(5):722-732.
            59.  Pei Z, Wang B, Chen G, Nagao M, Nakafuku M, Campbell      doi: 10.1016/j.neuron.2008.07.031
               K. Homeobox genes Gsx1 and Gsx2 differentially regulate   71.  Hundehege P, Fernandez-Orth J, Römer P, et al. Targeting
               telencephalic progenitor maturation.  Proc Natl Acad Sci   voltage-dependent  calcium  channels  with  pregabalin
               USA. 2011;108(4):1675-1680.                        exerts a direct neuroprotective effect in an animal model of
               doi: 10.1073/pnas.1008824108                       multiple sclerosis. Neurosignals. 2018;26(1):77-93.
            60.  Bishop JH, Faerman A, Geoly A, et al. Altered      doi: 10.1159/000495425.
               neurotransmitter ratio in the prefrontal cortex is   72.  Ablinger C, Geisler SM, Stanika RI, Klein CT, Obermair GJ.
               associated  with  pain  in  fibromyalgia  syndrome.  medRxiv.   Neuronal α2δ proteins and brain disorders. Pflügers Arch.
               2021;2021:21265618.                                2020;472(7):845-863.
               doi: 10.1101/2021.10.28.21265618                   doi: 10.1007/s00424-020-02420-2
            61.  Jiang H, Fang D, Kong L-Y, et al. Sensitization of neurons   73.  Bockbrader HN, Wesche D, Miller R, Chapel S, Janiczek
               in the central nucleus of the amygdala via the decreased   N, Burger P. A comparison of the pharmacokinetics and
               GABAergic  inhibition  contributes  to  the  development  of   pharmacodynamics of pregabalin and gabapentin.  Clin
               neuropathic pain-related anxiety-like behaviors in rats. Mol
               Brain. 2014;7:72.                                  Pharmacokinet. 2010;49(10):661-669.
               doi: 10.1186/s13041-014-0072-z                     doi: 10.2165/11536200-000000000-00000
                                                               74.  Mazzocchi A, Soker S, Skardal A. 3D bioprinting for high-
            62.  Alifragis P, Liapi A. Parnavelas JG. Lhx6 regulates the
               migration of cortical interneurons from the ventral   throughput  screening:  Drug  screening,  disease  modeling,
               telencephalon but does not specify their GABA phenotype. J   and  precision  medicine  applications.  Appl Phys Rev.
               Neurosci. 2004;24:5643-5648.                       2019;6(1):011302.
               doi: 10.1523/JNEUROSCI.1245-04.2004                doi: 10.1063/1.5056188
            63.  Good DJ, Braun T. NHLH2: at the intersection of obesity   75.  Satpathy A, Datta P, Wu Y, Ayan B, Bayram E, Ozbolat IT.
               and fertility. Trends Endocrinol Metab. 2013;24(8):385-390.  Developments with 3D bioprinting for novel drug discovery.
               doi: 10.1016/j.tem.2013.04.003                     Expert Opin Drug Discov. 2018;13(12):1115-1129.
                                                                  doi: 10.1080/17460441.2018.1542427
            64.  Takebayashi H, Yoshida S, Sugimori M, et al. Dynamic
               expression of basic helix-loop-helix Olig family members:   76.  Hwang DG, Choi YM, Jang  J. 3D bioprinting-based
               implication of Olig2 in neuron and oligodendrocyte   vascularized  tissue models mimicking tissue-specific
               differentiation and identification of a new member, Olig3.   architecture and pathophysiology for in vitro studies. Front
               Mech Dev. 2000;99:143-148.                         Bioeng Biotechnol. 2021;9:685507.
               doi: 10.1016/s0925-4773(00)00466-4                 doi: 10.3389/fbioe.2021.685507
            65.  Meijer DH, Kane MF, Mehta S, et al. Separated at birth? The   77.  Wu BX, Wu Z, Hou YY, et al. Application of three-
               functional and molecular divergence of OLIG1 and OLIG2.   dimensional (3D) bioprinting in anti-cancer therapy.
               Nat Rev Neurosci. 2012;13(12):819-831.             Heliyon. 2023;9(10):e20475.
               doi: 10.1038/nrn3386                               doi: 10.1016/j.heliyon.2023.e20475
            66.  Wang H, Xu L, Lai C, et al. Region-specific distribution of   78.  Peng W, Datta P, Ayan B, Ozbolat V, Sosnoski D, Ozbolat
               Olig2-expressing astrocytes in adult mouse brain and spinal   IT. 3D bioprinting for drug discovery and development in
               cord. Mol Brain. 2021;14:1-14.                     pharmaceutics. Acta Biomat. 2017;57:26-46.
               doi: 10.1186/s13041-021-00747-0                    doi: 10.1016/j.actbio.2017.05.025
            67.  Jakovcevski I, Zecevic  N. Olig transcription factors are   79.  Jorfi M, D’Avanzo C, Kim DY, Irimia, D. Three-dimensional
               expressed in oligodendrocyte and neuronal cells in human   models of the human brain development and diseases. Adv
               fetal CNS. J Neurosci. 2005;25(44):10064-10073.    Healthc Mater. 2018;7(1):10.1002/adhm.201700723.
               doi: 10.1523/JNEUROSCI.2324-05.2005                doi: 10.1002/adhm.201700723

            Volume 10 Issue 4 (2024)                       425                                doi: 10.36922/ijb.3010
   428   429   430   431   432   433   434   435   436   437   438